- Markets
- FMCG
- MKPL
MKPL
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
M K Proteins To Issue Bonus Shares To Shareholders In 2:1 Ratio
Jan 30 (Reuters) - M K Proteins Ltd MKPR.NS:
APPROVED ISSUANCE OF BONUS EQUITY SHARES TO EXISTING SHAREHOLDERS OF COMPANY IN RATIO OF 2:1
Source text for Eikon: ID:nBSE5B5J9t
Further company coverage: MKPR.NS
(([email protected];))
Jan 30 (Reuters) - M K Proteins Ltd MKPR.NS:
APPROVED ISSUANCE OF BONUS EQUITY SHARES TO EXISTING SHAREHOLDERS OF COMPANY IN RATIO OF 2:1
Source text for Eikon: ID:nBSE5B5J9t
Further company coverage: MKPR.NS
(([email protected];))
M K Proteins To Consider Issuance Of Bonus Shares
Jan 17 (Reuters) - M K Proteins Ltd MKPR.NS:
TO CONSIDER ISSUANCE OF BONUS SHARES
Source text for Eikon: ID:nBSE4Bhtwy
Further company coverage: MKPR.NS
(([email protected];))
Jan 17 (Reuters) - M K Proteins Ltd MKPR.NS:
TO CONSIDER ISSUANCE OF BONUS SHARES
Source text for Eikon: ID:nBSE4Bhtwy
Further company coverage: MKPR.NS
(([email protected];))
M K Proteins Says Vinod Kumar Designated As CFO, Whole-Time Director
Aug 23 (Reuters) - M K Proteins Ltd MKPR.NS:
VINOD KUMAR DESIGNATED AS WHOLE-TIME DIRECTOR, CFO
PARVIND KUMAR DESIGNATED AS CHAIRPERSON
Source text for Eikon: ID:nBSE5CSPj
Further company coverage: MKPR.NS
(([email protected];))
Aug 23 (Reuters) - M K Proteins Ltd MKPR.NS:
VINOD KUMAR DESIGNATED AS WHOLE-TIME DIRECTOR, CFO
PARVIND KUMAR DESIGNATED AS CHAIRPERSON
Source text for Eikon: ID:nBSE5CSPj
Further company coverage: MKPR.NS
(([email protected];))
M K Proteins Says Nipun Garg Resigns As CFO
Aug 21 (Reuters) - M K Proteins Ltd MKPR.NS:
NIPUN GARG RESIGNS AS CFO
Source text for Eikon: ID:nBSE68nP1G
Further company coverage: MKPR.NS
(([email protected];))
Aug 21 (Reuters) - M K Proteins Ltd MKPR.NS:
NIPUN GARG RESIGNS AS CFO
Source text for Eikon: ID:nBSE68nP1G
Further company coverage: MKPR.NS
(([email protected];))
M K Proteins Resumes Normal Operations At Office In Ambala
July 27 (Reuters) - M K Proteins Ltd MKPR.NS:
RESUMED NORMAL OPERATIONS AT OFFICE IN AMBALA
Source text for Eikon: [ID:]
Further company coverage: MKPR.NS
(([email protected];))
July 27 (Reuters) - M K Proteins Ltd MKPR.NS:
RESUMED NORMAL OPERATIONS AT OFFICE IN AMBALA
Source text for Eikon: [ID:]
Further company coverage: MKPR.NS
(([email protected];))
Events:
Bonus
Split
Bonus
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does MK Proteins do?
MK Proteins Limited is a company involved in the manufacturing and trading of a variety of edible oils by refining crude oils and producing by-products like Rice Bran Fatty Acid Oil and Rice Bran Wax.
Who are the competitors of MK Proteins?
MK Proteins major competitors are Vijay Solvex, Suraj Industries, Ambo Agritec, Ajanta Soya, Ambar Protein, Raj Oil Mills, Gokul Refoils & Solv. Market Cap of MK Proteins is ₹262 Crs. While the median market cap of its peers are ₹130 Crs.
Is MK Proteins financially stable compared to its competitors?
MK Proteins seems to be less financially stable compared to its competitors. Altman Z score of MK Proteins is 8.28 and is ranked 4 out of its 8 competitors.
Does MK Proteins pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. MK Proteins latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has MK Proteins allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is MK Proteins balance sheet?
Balance sheet of MK Proteins is strong. But short term working capital might become an issue for this company.
Is the profitablity of MK Proteins improving?
Yes, profit is increasing. The profit of MK Proteins is ₹11.43 Crs for TTM, ₹11.21 Crs for Mar 2024 and ₹10.93 Crs for Mar 2023.
Is the debt of MK Proteins increasing or decreasing?
The debt of MK Proteins is decreasing. Latest debt of MK Proteins is ₹0.23 Crs as of Sep-24. This is less than Mar-24 when it was ₹19 Crs.
Is MK Proteins stock expensive?
MK Proteins is not expensive. Latest PE of MK Proteins is 22.96, while 3 year average PE is 54.74. Also latest EV/EBITDA of MK Proteins is 16.2 while 3yr average is 21.39.
Has the share price of MK Proteins grown faster than its competition?
MK Proteins has given lower returns compared to its competitors. MK Proteins has grown at ~-49.15% over the last 2yrs while peers have grown at a median rate of 9.71%
Is the promoter bullish about MK Proteins?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in MK Proteins is 74.82% and last quarter promoter holding is 74.82%.
Are mutual funds buying/selling MK Proteins?
There is Insufficient data to gauge this.